Ovintiv Inc.OVVNYSE
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 76% recommend buying.

Consensus Rating
Buy
17 analysts·Moderate coverage
76%
Rating Distribution
Strong Buy
00%
Buy
1376%
Hold
424%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 27% higher.

Bear Case
$42.00
+6%
Consensus
$50.57
+27%
Bull Case
$55.00
+39%
Price Range17 analysts
Low
Consensus
High
$42.00
$55.00
Current Target
Current Price
$39.69
Upside to Target
$10.88

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 17, 2026Jefferies
Ovintiv price target raised to $54 from $52 at Jefferies
Target:$54.00
+36.1%from $39.69
Dec 12, 2025UBS
Ovintiv price target raised to $55 from $54 at UBS
Target:$55.00
+34.9%from $40.76
Nov 21, 2025UBS
Ovintiv price target raised to $54 from $52 at UBS
Target:$54.00
+40.0%from $38.56
Nov 6, 2025Evercore ISI
Ovintiv price target raised to $47 from $43 at Evercore ISI
Target:$47.00
+25.0%from $37.59
Oct 15, 2025RBC Capital
Ovintiv upgraded to Outperform from Sector Perform at RBC Capital
Target:$55.00
+49.4%from $36.81
Oct 14, 2025Morgan Stanley
Ovintiv price target lowered to $46 from $48 at Morgan Stanley
Target:$46.00
+23.0%from $37.41
Oct 13, 2025Roth Capital
Ovintiv initiated with a Neutral at Roth Capital
Target:$42.00
+10.6%from $37.99
Oct 7, 2025Barclays
Ovintiv price target lowered to $55 from $57 at Barclays
Target:$55.00
+37.3%from $40.07
Aug 18, 2025Morgan Stanley
Ovintiv downgraded to Equal Weight from Overweight at Morgan Stanley
Target:$48.00
+21.8%from $39.40
Apr 15, 2025Morgan Stanley
Ovintiv price target lowered to $50 from $57 at Morgan Stanley
Target:$50.00
+54.9%from $32.28
Mar 26, 2025Morgan Stanley
Ovintiv resumed with an Overweight at Morgan Stanley
Target:$57.00
+27.8%from $44.59
Mar 24, 2025BMO Capital
Ovintiv upgraded to Outperform from Market Perform at BMO Capital
Target:$57.00
+32.5%from $43.01
Mar 20, 2025Wells Fargo
Ovintiv price target raised to $45 from $44 at Wells Fargo
Target:$45.00
+6.8%from $42.12
Mar 5, 2025Williams Trading
Ovintiv price target lowered to $58 from $68 at Siebert Williams
Target:$58.00
+51.8%from $38.22
Jan 3, 2025Wolfe Research
Ovintiv price target raised to $70 from $65 at Wolfe Research
Target:$70.00
+67.4%from $41.80
Oct 28, 2024Truist Financial
Truist Securities Reiterates Buy Rating on Ovintiv Inc. (OVV)
Target:$47.00
+19.3%from $39.41
Oct 15, 2024Williams Trading
Ovintiv price target raised to $60 from $57 at Siebert Williams
Target:$60.00
+41.0%from $42.54
Oct 1, 2024Wells Fargo
Ovintiv price target lowered to $42 from $51 at Wells Fargo
Target:$42.00
+9.6%from $38.31
Sep 30, 2024Evercore ISI
Ovintiv price target lowered to $54 from $60 at Evercore ISI
Target:$54.00
+40.7%from $38.37
Jul 22, 2024Truist Financial
Ovintiv Inc. (OVV) PT Lowered to $60 at Truist Securities
Target:$60.00
+28.3%from $46.78
Jul 17, 2024Wolfe Research
Ovintiv reinstated with an Outperform at Wolfe Research
Target:$65.00
+34.1%from $48.47
Jun 14, 2024Evercore ISI
Evercore ISI Upgrades Ovintiv Inc. (OVV) to Outperform
Target:$60.00
+28.1%from $46.83
May 9, 2024RBC Capital
Ovintiv Inc. (OVV) PT Raised to $62 at RBC Capital
Target:$62.00
+21.8%from $50.91
Apr 9, 2024Barclays
Ovintiv initiated with an Overweight at Barclays
Target:$69.00
+24.2%from $55.56
Apr 5, 2024Truist Financial
Ovintiv price target raised to $68 from $63 at Truist
Target:$68.00
+24.0%from $54.85